On a molecular level, tumors can be roughly dichotomized as NF2 (neurofibromatosis type 2) and non-NF2-mutated meningiomas, and NF2 is the main identified driver mutation in atypical meningiomas [9,10]. The gene discussed is NF2; the disease is meningioma.